Docusate/Senna for the Treatment of Diabetic Gastroparesis

Status Terminated

Clinical Trial Summary

The aim of the study is to evaluate the efficacy of the stimulant laxative Senokot-S® for the treatment of diabetic gastroparesis. Senokot-S, and its metabolites, are thought to produce peristalsis, drive intraluminal fluid and electrolyte shifts, and have an irritant effect on the gut mucosa. These complex physiologic mechanisms appear may sufficiently promote stomach emp-tying, and thereby reduce or eliminate the severity of gastroparesis symptoms. In this open label study, participants will be randomized into high and low dose groups to assess for ideal dosing and tolerability. It is the overall goal of this study to select the most promising dose-strength for the treatment of mild through severe gastroparesis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03342157
Study type	Interventional
Source	Aurora Health Care
Contact
Status	Terminated
Phase	Phase 2
Start date	April 2, 2018
Completion date	August 17, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01557296` - Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis	Phase 2
Withdrawn	`NCT03376399` - Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
Not yet recruiting	`NCT02264587` - Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis	Phase 4
Completed	`NCT02289846` - Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)	Phase 2
Completed	`NCT03544229` - A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis	Phase 2
Recruiting	`NCT04706832` - Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study	N/A
Not yet recruiting	`NCT05584462` - Gastroparesis in type2 Diabetic Patient
Enrolling by invitation	`NCT05812339` - Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
Completed	`NCT02732821` - G-POEM for Treatment of Refractory Gastroparesis
Completed	`NCT01030341` - Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis	N/A
Recruiting	`NCT05832151` - A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Phase 2
Completed	`NCT02025725` - Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis	Phase 3
Completed	`NCT01916460` - Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients	N/A
Completed	`NCT01469286` - Transcutaneous Electroacupuncture for Gastroparesis	Phase 1
Terminated	`NCT00874133` - The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis	N/A
Completed	`NCT01126034` - Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention	N/A
Recruiting	`NCT05273788` - Thoracic Neuromodulation for Diabetic Gastroparesis	N/A
Suspended	`NCT00470795` - Acupuncture for Diabetic Gastroparesis	Phase 3
Completed	`NCT00139893` - A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis	N/A
Recruiting	`NCT04254549` - Rifaximin in Patients With Diabetic Gastroparesis	Phase 2